Clinical Trial Update: Elvitegravir (EVG) Cerebrospinal Fluid (CSF) Pharmacokinetics in HIV-Infected Individuals [NA]

View source ↗

Summary

Clinical trial update reporting on cerebrospinal fluid pharmacokinetics of elvitegravir in HIV-infected individuals; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids

Drugs mentioned

• elvitegravir (elvitegravir)

Snippet

Sponsor: University of California, San Diego | Conditions: HIV | NA | Status: COMPLETED | Results posted: 2019-10-31